NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Billion in Credit Provided to Its Users27/01/2026PR Newswire
Asthma and Allergy Drug Development Is Failing Too Often–A Translational Reset Is Needed: HKEY-AIRx™1.027/01/2026PR Newswire
FutureMain Bolsters Global Industrial AI Competitiveness with NPU-Based Time-Series AI Project27/01/2026PR Newswire
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies27/01/2026PR Newswire
Antigravity Updates A1 with Virtual Flight Simulator and Announces 15% Off US Sale27/01/2026PR Newswire
Phemex Introduces Elite Trader Recruitment Program Focused on Professional Copy Trading27/01/2026PR Newswire
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease27/01/2026PR Newswire
Skyhawk Therapeutics ประกาศผลวิเคราะห์ระหว่างกาลระยะ 9 เดือนในผู้ป่วยจากการทดลองทางคลินิกระยะที่ 1 ของ SKY-0515 เพื่อการรักษาโรค Huntington27/01/2026PR Newswire
Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer27/01/2026PR Newswire
